Dr. Jane E. Carleton
Overview
Dr. Carleton, MD, is Associate Chief of the R.J. Zuckerberg Cancer Center at the Northwell Health Cancer Institute. Dr. Carleton, an expert in the treatment of breast cancer, joined the staff at North Shore University Hospital in 2002. A Massachusetts native, Dr. Carleton graduated from the University of Massachusetts Medical School and completed both her residency in Internal Medicine and fellowship in Hematology/Oncology at Tufts Medical Center in Boston. She then conducted two years of hematology research at the Beth Israel Deaconess Medical Center in Boston. Since joining the Northwell Health System she has focused her career primarily on breast cancer, including breast cancer prevention and the management of early stage and advanced breast cancer. She is actively involved in multidisciplinary disease oriented care models for these diseases. In addition to patient care she is actively involved in the education of medical students, residents and fellows, and participates in clinical research on breast cancer. She is an Assistant Professor of Medicine at the Hofstra Northwell School of Medicine.
Dr. Carleton is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Breast Cancer.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 1 clinical trial in the study of HER2 Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Lakeville Road, Entrance B, Lake Success, NY 11042
Additional Areas of Focus
Dr. Carleton has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Icahn School Of Medicine At Mount Sinai
Amy Tiersten is an Oncologist in New York, New York. Dr. Tiersten is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma.
Yale University
Lajos Pusztai is an Oncologist in New Haven, Connecticut. Dr. Pusztai is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Triple-Negative Breast Cancer, Breast Cancer, Inflammatory Breast Cancer, HER2 Negative Breast Cancer, and Tissue Biopsy.
Trustees Of Columbia University In The City Of New York
Katherine Crew is an Oncologist in New York, New York. Dr. Crew is rated as a Distinguished provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Carleton isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Carleton isDistinguished. Learn about Breast Cancer.
- Inflammatory Breast CancerDr. Carleton isDistinguished. Learn about Inflammatory Breast Cancer.
- Intraductal PapillomaDr. Carleton isDistinguished. Learn about Intraductal Papilloma.
- Paget Disease of the BreastDr. Carleton isDistinguished. Learn about Paget Disease of the Breast.
- Experienced
- Adult Immune ThrombocytopeniaDr. Carleton isExperienced. Learn about Adult Immune Thrombocytopenia.
- ALK-Positive Non-Small Cell Lung CancerDr. Carleton isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Carleton isExperienced. Learn about Anemia.
- BRCA Positive Breast CancerDr. Carleton isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Carleton isExperienced. Learn about Breast Cancer in Men.
- Childhood Acute Myeloid LeukemiaDr. Carleton isExperienced. Learn about Childhood Acute Myeloid Leukemia.